Advertisement
Screener

CARDIFF ONCOLOGY, INC. (CRDF) Preferred Stock, Shares Authorized

2.0 / 5 stars · 44/111 Roast Me

CARDIFF ONCOLOGY, INC. Preferred Stock, Shares Authorized

CARDIFF ONCOLOGY, INC. (CRDF) had Preferred Stock, Shares Authorized of 20.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-11

  • 2026-06-30: Preferred Stock, Shares Authorized 20.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 20.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 20.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 20.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-3020.00M shares
10-Q · filed 2026-08-11
2026-03-3120.00M shares
10-Q · filed 2026-05-14
2025-12-3120.00M shares
10-Q · filed 2026-08-11
2025-09-3020.00M shares
10-Q · filed 2025-11-06
2025-06-3020.00M shares
10-Q · filed 2025-07-29
2025-03-3120.00M shares
10-Q · filed 2025-05-08
2024-12-3120.00M shares
10-K · filed 2026-02-24
2024-09-3020.00M shares
10-Q · filed 2024-11-07
2024-06-3020.00M shares
10-Q · filed 2024-08-08
2024-03-3120.00M shares
10-Q · filed 2024-05-02
2023-12-3120.00M shares
10-K · filed 2025-02-27
2023-09-3020.00M shares
10-Q · filed 2023-11-02
2023-06-3020.00M shares
10-Q · filed 2023-08-09
2023-03-3120.00M shares
10-Q · filed 2023-05-04
2022-12-3120.00M shares
10-K · filed 2024-02-29
2022-09-3020.00M shares
10-Q · filed 2022-11-03
2022-06-3020.00M shares
10-Q · filed 2022-08-04
2022-03-3120.00M shares
10-Q · filed 2022-05-05
2021-12-3120.00M shares
10-K · filed 2023-03-02
2021-09-3020.00M shares
10-Q · filed 2021-11-04
2021-06-3020.00M shares
10-Q · filed 2021-08-05
2021-03-3120.00M shares
10-Q · filed 2021-05-06
2020-12-3120.00M shares
10-K · filed 2022-02-24
2020-09-3020.00M shares
10-Q · filed 2020-11-05
2020-06-3020.00M shares
10-Q · filed 2020-08-11
2020-03-3120.00M shares
10-Q · filed 2020-05-07
2019-12-3120.00M shares
10-K · filed 2021-02-25
2019-09-3020.00M shares
10-Q · filed 2019-11-07
2019-06-3020.00M shares
10-Q · filed 2019-08-08
2019-03-3120.00M shares
10-Q · filed 2019-05-07
2018-12-3120.00M shares
10-K · filed 2020-02-27
2018-09-3020.00M shares
10-Q · filed 2018-11-07
2018-06-3020.00M shares
10-Q · filed 2018-08-03
2018-03-3120.00M shares
10-Q · filed 2018-05-08
2017-12-3120.00M shares
10-K · filed 2019-03-06
2017-09-3020.00M shares
10-Q · filed 2017-11-09
2017-06-3020.00M shares
10-Q · filed 2017-08-09
2017-03-3120.00M shares
10-Q · filed 2017-05-10
2016-12-3120.00M shares
10-K · filed 2018-02-26
2016-09-3020.00M shares
10-Q · filed 2016-11-09
2016-06-3020.00M shares
10-Q · filed 2016-08-04
2016-03-3120.00M shares
10-Q · filed 2016-05-10
2015-12-3120.00M shares
10-K · filed 2017-03-15
2015-09-3020.00M shares
10-Q · filed 2015-11-09
2015-06-3020.00M shares
10-Q · filed 2015-08-10
2015-03-3120.00M shares
10-Q · filed 2015-05-05
2014-12-3120.00M shares
10-K · filed 2016-03-10
2014-09-3020.00M shares
10-Q · filed 2014-11-06
2014-06-3020.00M shares
10-Q · filed 2014-08-07
2014-03-3120.00M shares
10-Q · filed 2014-05-12
2013-12-3120.00M shares
10-K · filed 2015-03-12
2013-09-3020.00M shares
10-Q · filed 2013-11-14
2013-06-3020.00M shares
10-Q · filed 2013-08-14
2013-03-3120.00M shares
10-Q · filed 2013-05-14
2012-12-3120.00M shares
10-K · filed 2014-03-17
2012-09-3020.00M shares
10-Q · filed 2012-11-14
2012-06-3020.00M shares
10-Q · filed 2012-08-14
2012-03-3120.00M shares
10-Q · filed 2012-05-15
2011-12-3120.00M shares
10-K · filed 2013-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Vaxart, Inc. (VXRT)United States$0.080B3.84
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B